These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 2446590)

  • 21. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW; Toner GC; Geller NL; Bosl GJ
    Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).
    Donohue JP; Thornhill JA; Foster RS; Bihrle R; Rowland RG; Einhorn LH
    J Urol; 1995 Jan; 153(1):85-9. PubMed ID: 7966799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
    Takasaki N; Ueda H; Isurugi K
    Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
    J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
    Logothetis CJ; Samuels ML; Selig DE; Johnson DE; Swanson DA; von Eschenbach AC
    J Urol; 1985 Dec; 134(6):1127-30. PubMed ID: 2414470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer.
    Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH
    J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
    Sparwasser C; Treiber U; Beckert R; Pust RA
    Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent testis cancer: seeding from retroperitoneal nodes after complete remissions by chemotherapy.
    Kamer M; Rowland RG; Einhorn LH; Donohue JP
    J Urol; 1983 Dec; 130(6):1196-8. PubMed ID: 6196491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Sheinfeld J
    Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.
    Lerner SE; Mann BS; Blute ML; Richardson RL; Zincke H
    Mayo Clin Proc; 1995 Sep; 70(9):821-8. PubMed ID: 7543967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer.
    Pizzocaro G
    Eur J Surg Oncol; 1986 Mar; 12(1):25-8. PubMed ID: 3007218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB; Steele GS; Richie JP
    J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage II nonseminomatous germ-cell testicular tumors--the Indiana experience and risk-benefit analysis.
    Foster RS; Bihrle R; Little JS; Rowland RG; Donohue JP
    World J Urol; 1994; 12(3):143-6; discussion 147. PubMed ID: 7524921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.